Study protocol: a cross-sectional survey of seasonal affective disorder in Danish populations with and without severe visual impairments by Madsen, Helle Østergaard et al.
Study protocol: a cross-sectional survey
of seasonal affective disorder in Danish
populations with and without severe
visual impairments
Helle Østergaard Madsen, Henrik Dam, Ida Hageman
ABSTRACT
Introduction: People with seasonal affective disorder
(SAD) experience recurrent seasonal ﬂuctuations in
energy, mood and appetite. Retinal light exposure is
suggested to play an important role in the
pathogenesis and treatment of SAD. The aim of the
study is to determine the prevalence of SAD in persons
with severe visual impairments or blindness and to
compare the results to a control group without visual
impairments. Moreover, the authors wish to
investigate whether SAD is correlated to the degree of
impairment or to the diagnosis.
Methods and analysis: 2781 persons with visual
impairments ranging from total blindness to Snellen
visual acuity 6/60 receive information letter and
questionnaire by post. Completed questionnaires can
be returned by post, email or telephone. For each
respondent, all eye-related diagnoses will be obtained
from national registries. Normally sighted and
demographically matched control respondents will be
contacted in a similar manner the subsequent winter
season. The Seasonal Pattern Assessment
Questionnaire rates seasonal variation within the six
items: sleep, appetite, social activity, mood, energy
and body weight. The Seasonal Pattern Assessment
Questionnaire yields a Global Seasonal Score and
a prevalence of SAD. Outcomes from the two groups
will be compared. Moreover, outcomes from
subgroups of the visually impaired population will be
compared.
Ethics and dissemination: The study is approved by
the Danish Data Protection Agency. Results will be
published in a relevant scientiﬁc journal and be
communicated to respondents and relevant
institutions through cooperation with the Danish
Association of the Blind.
INTRODUCTION
Seasonal affective disorder (SAD) or winter
depression is a syndrome of seasonally
occurring reductions in mood, energy and
social initiative along with increases in appe-
tite, body weight and sleep duration.
1 The
effectiveness of light therapy in the treatment
of SAD was established in a 2005 meta-anal-
ysis reporting effect sizes of 0.84 (CI 0.60 to
1.08) for bright white light and 0.73 (CI 0.37
to 1.08) for dawn simulation, the two most
prominent types of light therapy.
2 Merely
ocular, not cutaneous, exposure is effective in
alleviating symptoms.
3 On this background, it
is assumed likely that diminished retinal light
exposure plays a signiﬁcant role in the
development of each case of SAD.
4
For SAD patients, photoperiod (day
length), hours of sunshine and global radia-
tion are the strongest climatic predictors for
onset of disease.
5 However, the suggested
correlation between SAD prevalence and
latitude of living only receives weak
support from published meta-analysis.
6 The
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ARTICLE SUMMARY
Article focus
- The prevalence of SAD in a visually impaired
population.
- The prevalence of SAD correlated to degree of
visual impairment or type of impairment.
Key messages
- Any association between visual impairment and
SAD will add to current knowledge of the role of
retinal light exposure in the development of SAD.
- The occurrence of SAD in visually impaired
populations is a previously uninvestigated area
that may hold non-pharmacological therapeutic
potential to many people.
Strengths and limitations of this study
- Through use of the vast national registries of the
Danish Health System and our cooperation with
a major Danish organisation for blind and visually
impaired persons, we have unique access to
a large identiﬁable study population with visual
impairment.
- The applied questionnaire has undergone wide-
spread use allowing for comparisons between
many different populations despite its diagnostic
limitations.
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Open Access Protocolassociation between SAD and melatonergic disturbances
remains unclear. A single study has found an increase in
the duration of nocturnal melatonin secretion in male
SAD patients compared with healthy controls.
7 The
phase shift hypothesis suggests that SAD is caused by
a fall/winter delay in circadian rhythms.
8 Approximately
50% of SAD patients seem to exhibit a shift in the
evening onset of melatonin secretion compared with
healthy controls. This shift can be corrected by properly
timed light therapy. Some studies have even found an
association between the degree of phase correction
obtained by light therapy and the concurrent reduction
in depressive symptoms, but the causal relation between
these factors remain unresolved.
9
The overall retinal electrical response to light,
measured by electrooculographic ratio, is found reduced
in some studies of SAD patients.
10 Other trials exam-
ining different measures of retinal status have yielded
diverging and non-conclusive results.
11
Light can effectively suppress melatonin secretion in
blind individuals with no conscious light perception
(NLP) through newly identiﬁed pathways of the non-
image-forming visual system, for example, melanopsin-
containing intrinsically photosensitive retinal ganglion
cells.
12 13 The photopigment, melanopsin, demonstrates
a peak spectral sensitivity to light with wavelengths of
460 nm, which is blue light. In new light therapy studies
of SAD, blue light appears to be as effective as bright
white light, suggesting an involvement of the mela-
nopsin-dependent pathways in the treatment.
14 Prelimi-
nary investigations have found associations between SAD
and a mutated variant of the melanopsin gene, but
reproduction of this ﬁnding is warranted.
15
Sleep disorders are a frequent complaint in NLP
individuals, particularly in persons who have had one or
both eyes removed.
16 17 Blind adolescents with optical
nerve damage (eg, glaucoma, diabetic retinopathy) are
more prone to circadian disturbances than controls with
other eye conditions.
18
Seasonal mood and energy variation is a common
complaint in the northern hemisphere with SAD being
the endpoint of a vast continuum. Screening studies
from the Northern countries report prevalence estimates
ranging from 3% to 12%.
6 19 Traditionally, the syndrome
has not been considered as disabling as classical
depression, but during symptomatic episodes, SAD
patients report reductions in quality of life equal to those
experienced by individuals with classical major depres-
sive disorder.
20 21 On this background of a commonly
occurring phenomenon with unclariﬁed pathogenetic
relations, we designed a survey to investigate the preva-
lence of SAD in a population with severe visual impair-
ments or total blindness.
OBJECTIVES
The study has fourfold aims:
a. to determine SAD prevalence and extent of symp-
tomatology in a Danish population of blind and
visually impaired persons,
b. to compare the ﬁndings to a control group without
visual impairments matched on gender, age and
residential area,
c. to clarify whether SAD prevalence and extent of
symptomatology correlate to the degree of visual
impairment (light perception vs no light perception)
and
d. to investigate whether SAD prevalence and the extent
of symptomatology correlate to the type of visual
impairment (anatomic localisation, congenital or
acquired genesis).
METHODS
Design and setting
The study is a cross-sectional survey investigating the
prevalence and symptomatology of SAD in a primary
study population with severe visual impairments or total
blindness compared with a sighted control population.
The two surveys (study and control population) will be
undertaken during consecutive winter seasons.
For all rounds of data collection, a similar methodology
and time schedule will be applied. Postal send-outs are
scheduled in October/November followed by a 1- to 2-
months response period before starting a follow-up round
of telephone interviews that extends into the subsequent
year. Non-responders are attemptedly contacted by tele-
phone on one to three separate occasions if a relevant
telephone number can be attained.
Participants
Study population
All 2781 members of the Danish Association of the Blind
(DAB) between 18 and 65 years of age are invited to
participate in the study. DAB is an independent private
organisation with approximately 12000 blind and visu-
ally impaired members, corresponding to 50% of all
blind and visually impaired persons in Denmark.
Membership requires corrected sight equal to or less
than Snellen visual acuity 6/60 in the eye with better
vision. The vision loss must be documented by an
ophthalmologist.
Prior to the study, a notice of the study is given in the
DAB membership journal. Consequently, all members
receive a normal print information letter and question-
naire along with a copy in either enlarged print (font
Arial, size 18), braille font, audio disc or email. Ques-
tionnaire table items are transformed into single ques-
tions to avoid the obstacle of ticking off answers.
Production of accessible means of information for visu-
ally impaired persons is obtained by advise from the
DAB.
A prepaid return envelope is enclosed within all send-
outs. Completed questionnaires can be returned by post
or email. In addition, a contact telephone number is
provided, and the research group is available for tele-
phone interviews on all weekdays. If no answer is
returned by post or email within 2 months, the member
is contacted by telephone.
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A control group is identiﬁed through the Danish Civil
Registration System where all Danish citizens are registered
by personal social security number. The control group is
matched to the study popula t i o no ni m p o r t a n td e m o -
graphic variables: gender, age and residential area (postal
code). Telephone numbers are obtained from a private
telephone register (Eniro). To ensure that controls do
not suffer severe visual impairments, the questionnaire
contains a question regarding potential eye conditions.
Outcomes
Demographic variables
Respondents are asked to ﬁll out name, gender, age and
postal code. Study respondents are asked to ﬁll out their
social security number. If controls wish to answer anon-
ymously, they can omit stating their name. If study
respondents wish to answer anonymously, their data are
only used for analysis of aim (a), (b) and (c) since their
diagnosis thus cannot be attained from the registers.
Degree of visual impairment
To assess the respondents’ degree of visual impairment,
the questionnaire sent to the study population contains
three questions regarding the ability to detect light, to
determine source and direction of light or to count
ﬁngers at a distance of 1 m from the eyes. These ques-
tions were conferred with the board of DAB before
adding them to the questionnaire.
On the basis of the questionnaire replies, the study
population can be divided into four groups according to
degree of visual impairment.
Type of visual impairment
For each respondent in the study group, all registered
relevant eye-related diagnoses and surgical procedures
including date of contact to the hospital are obtained
from the Danish National Patient Registry (table 1). The
register contains data (date, hospital, diagnosis, treatment
actions, etc.) of all contacts made to the public medical
system identiﬁable through social security number. Diag-
noses will be categorised according to genesis (congenital
or acquired) and to anatomical localisation.
From 1977 to 1993, a different set of registration codes
was used in the Danish Medical System. Records from
these years are searched by their corresponding codes.
Seasonal variation
To evaluate self-reported seasonal variation, an existing
Danish translation of The Seasonal Pattern Assessment
Questionnaire (SPAQ) is used. The main component of
SPAQ is a six-item scale where the respondent rates the
variation he/she experiences across the seasons. The six
items (sleep duration, social activity, mood, appetite,
weight and energy) are each rated from 0 to 4 points.
The sum score yields the Global Seasonal Score (GSS) of
a maximum of 24 points. In addition, the respondent
must rate to which extent the variation constitutes
a problem and state during which months he/she feels
worst. The cut-off score for SAD was originally set by
Kasper et al at 11 or higher. Moreover, the variation has
to constitute at least a moderate problem and the
respondent must feel worst in a winter month
(November, December, January, February). The SPAQ
also deﬁnes a milder form of seasonal malaise, subsyn-
dromal seasonal affective disorder (sSAD). Two SPAQ
deﬁnitions of sSAD exist: (a) GSS$10 and the variation
rated as no or only a mild problem or (b) GSS of 8 or 9
with the problem rated as at least a mild problem.
6
The SPAQ has been widely used in epidemiological
studies on SAD. The questionnaire does not have the
properties of a diagnostic tool but is validated for use as
a screening instrument. Its clinical validity has been
discussed in recent years but its brief and simple
construction and widespread use make it suitable for
epidemiological research.
22
Bias
Non-response
There may be a tendency that people are more inclined
to answer the questionnaire if they are familiar with the
current subject/suffer from the investigated condition.
This situation will inﬂate the prevalence estimate found
in our sample in case of substantial non-response.
We attempt to evade this problem by informing the
respondents of their value to the study even though
they do not experience seasonal variation. Moreover,
a comprehensive effort is put into follow-up by
contacting as many as possible by telephone and offering
them a short telephone interview. The estimates from
the two populations can be correctly compared even if
they do not reﬂect the actual prevalence of SAD.
Recall bias
Due to the fact that we exclusively contact each respon-
dent at one occasion, there is a risk that respondents
Table 1 Data from the Danish National Patient Registry
according to Sundhedsvæsenets Klassiﬁkations System
(SKS classiﬁcation)
ICD code
of diseases
Corresponding diagnosis
DH0-DH59 Diseases related to eye and
eye surroundings
DQ10-DQ15 Congenital diseases related to eyes
DS05 Lesion of eye and orbita
DC69 Cancer of eye and eye surroundings
DE703 Albinism
ICD code
of surgery
Corresponding operation
KCAD Removal of orbital content
KCAE Surgery by anophthalmia after
enucleation/evisceration of eye
KCDC Enucleation and exenteration of
the eye
ICD code
of treatment
Corresponding treatment
BCDE Treatment with eye prosthesis
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year instead of reporting a problem of a recurring
nature. The Diagnostic and Statistical Manual of Mental
Disorder (DSM-IV) criteria points out that the variation
must be a recurring problem over consecutive seasons.
We ask how much variation the respondent experiences
across the seasons in general. The phrasing of the
question is an attempt to evade this bias.
Selection bias
We believe to have contacted at least 50% of the Danish
visually impaired population between the age of 18e65.
DAB is a private institution that attempts to reach all
eligible members. The board of DAB judges that there is
no systematic bias in who chooses to be a member of their
organisation. Their members are randomly distributed
across demographic factors such as age, gender, income
and educational level, aetiology of impairment etc.
The control group is randomly assigned on the basis of
their age, gender and residential area and we therefore
believe them to be a valid sample of the background
population.
Sample size
A Danish survey from 1993 to 1994 found that 12% of
a randomly chosen Danish population met the Kasper
criteria for SAD.
19 We primarily wish to investigate
whether the prevalence among blind and visually
impaired persons exceed 12%+5%¼17%. By calculations
using the SPSS sample Power V.2.0, 2004, the group of
visually impaired persons must include 1260 persons or
more to obtain a power of 0.95 and 1041 persons to
obtain a power of 0.90. To reach adequate numbers, all
2781 eligible members of DAB are contacted.
Expecting a response rate of approximately 50% in the
control group, it must include at least 231260¼2520
matched persons.
Data analysis and statistics
Data will be analysed in SPSS V.17.0. For each group
(study and control group, including subgroups with/
without light perception), age (mean), gender distribu-
tion and residential distribution will be reported.
GSS will be reported by medians and IQR. Correla-
tions between age and GSS will be tested by the
Spearman correlation test for each group and gender
separately. GSS differences between groups will be tested
by non-parametric methods, the ManneWhitney U test
for comparing two medians and the KruskaleWallis
test for comparing more than two medians. The
medians and the corresponding p values for performed
comparisons will be reported.
The prevalence of SAD and sSAD will be reported as
proportions. Comparisons between groups will be tested
by use of the c
2 test. For each group, the proportion of
respondents reporting no seasonal variation (GSS ¼0)
will be reported and compared with other groups. In
comparisons, the estimated proportions and test p values
will be reported.
DISCUSSION
This study aims to investigate seasonal variation in
emotional and behavioural parameters in a population
of persons with severe visual impairments compared with
a normally sighted control group. Any ﬁndings of
differentiated patterns between subgroups of the study
will support the hypothesis that light plays a role in the
pathogenesis of SAD. To our knowledge, this is the ﬁrst
study survey to address this question.
There are various risks of bias associated with the study.
The subdivision of study population respondents based
on self-reported degree of visual impairment poses some
uncertainty. Based on the ﬁrst responses received, we see
that some respondents have difﬁculties answering the
questions or report ﬂuctuations in the severity of their
visual impairment. By the advice of our DAB contacts, we
rely on the respondents’ correct report of their ability to
perceive light and we will therefore solely use this
parameter to differentiate between degrees of impair-
ment. The SPAQ is based on self-report and thus holds
a basis for recall bias. Our results should therefore be
interpreted in terms of differentiated patterns of
seasonality between groups with different visual capacities
but not as estimates of the actual prevalence of SAD in
our populations. The obtained prevalence estimates will
also be valuable for comparisons with other groups (other
nations, subgroups, etc) investigated by use of the SPAQ.
The SPAQ has been shown to lack power in separating
seasonally depressed patients from non-seasonally
depressed patients.
22 This fact could bias the results
since depression/affective disorders are a major
complaint in populations with visual impairments.
23
Investigations have however primarily been performed
in elderly populations with visual impairments, and the
ﬁndings may not necessarily extrapolate to our younger
study population. Moreover, there are no indications
that people with severe visual impairments should be
more prone to affective disorders than people who are
profoundly blind. The association between visual
impairment and depression will therefore not inﬂuence
the differences in the prevalence estimates for different
subgroups (+/  light perception).
A risk of bias exist in the fact that people who are
profoundly blind do not suffer the same dependence on
lighting as less severely impaired or sighted individuals.
NLP respondents may therefore experience less seasonal
variation in, for example, social activities since the
wintertime darkness does not practically limit their
activities. To evade this problem or at least to evaluate
the extent of the problem, it may be possible to perform
analysis on the single questionnaire items since variation
in some items cannot be explained by increased practical
obstacles connected to darkness for the sighted
subgroups (sleep, appetite).
An important perspective of the study is to raise
awareness about the problem of SAD in the Danish
visually impaired population. In this group of people,
the syndrome is easily neglected, partly due to the
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in light can hold importance to visually impaired people
or that light therapy can be effective in their treatment.
From the recent increase in knowledge of the non-
image-forming visual system, it seems reasonable to
believe that seasonal variation in mood and behaviour
may very well constitute a problem in this group. It also
seems probable that the mood swings can be prevented
with light therapy in visually impaired or even
profoundly blind individuals. Light therapy treatment
perspectives for visually impaired persons with SAD
could be investigated in a randomised clinical trial with
eligible respondents from our study, preferably from
different impairment groups. In such a study, it will of
course be necessary to perform actual clinical and
paraclinical assessments of the state of vision.
In summary, it remains unclear how SAD development
is related to reductions in retinal light exposure. This
cross-sectional study of the prevalence of SAD in groups
of people with visual impairments ranging from severe
impairments to total blindness seeks to elucidate part of
the question.
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